---
title: "Immuneering (IMRX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/IMRX.US/norm.md"
symbol: "IMRX.US"
name: "Immuneering"
parent: "https://longbridge.com/zh-CN/quote/IMRX.US.md"
datetime: "2026-05-21T17:39:27.591Z"
locales:
  - [en](https://longbridge.com/en/quote/IMRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMRX.US/norm.md)
---

# Immuneering (IMRX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2081 | -0.1793 | -0.3772 | -0.4011 | -0.4235 |
| ROE | -25.34% | -20.75% | -46.60% | -163.14% | -144.62% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -13.46M | -11.58M | -14.96M | -14.43M | -15.05M |
| 营业利润 | -15.34M | -13.75M | -15.38M | -14.76M | -15.48M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 214.81M | 231.99M | 241.06M | 40.06M | 50.68M |
| 权益乘数 | 1.04 | 1.06 | 1.06 | 1.38 | 1.21 |
| 每股净资产 | 3.19 | 3.38 | 3.59 | 0.8041 | 1.16 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 156.69M | 172.83M | 227.56M | 26.36M | 35.87M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 4.17M | 4.26M | 4.30M | 4.46M | 4.63M |
| 净债务 | -194.91M | -213.19M | -223.65M | -22.35M | -31.78M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -18.43M | -9.84M | -11.98M | -9.45M | -14.08M |
| 投资现金流 | -63.07M | -88.72M | -7255.00 | -2116.00 | -8945.00 |
| 融资现金流 | 180760.00 | -357523.00 | 213.19M | -61958.00 | 13.81M |
| 自由现金流 | -15.99M | -8.36M | -6.20M | -4.27M | -9.21M |
| 现金流充裕率 | -23061.98% | -7941.73% | -165089.39% | -446414.18% | -157413.50% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -79930.00 | -123910.00 | -7255.00 | -2116.00 | -8945.00 |